Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)

Antonio Vitale; Giacomo Emmi; Giuseppe Lopalco; Claudia Fabiani; Stefano Gentileschi; Elena Silvestri; Gerardo Di Scala; Florenzo Iannone; Bruno Frediani; Mauro Galeazzi; Giovanni Lapadula; Donato Rigante; Luca Cantarini

doi:10.1007/s10067-018-4302-0

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)

Antonio Vitale, Giacomo Emmi, Giuseppe Lopalco, Claudia Fabiani, Stefano Gentileschi, Elena Silvestri, Gerardo Di Scala, Florenzo Iannone, Bruno Frediani, Mauro Galeazzi, Giovanni Lapadula, Donato Rigante, Luca Cantarini

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

A correction is reported in comparison with the original version of the paper.

Lingua originale	English
pagine (da-a)	267-267
Numero di pagine	1
Rivista	Clinical Rheumatology
Volume	38
DOI	https://doi.org/10.1007/s10067-018-4302-0
Stato di pubblicazione	Pubblicato - 2019

Keywords

Behçet's disease

Accesso al documento

10.1007/s10067-018-4302-0

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Vitale, A., Emmi, G., Lopalco, G., Fabiani, C., Gentileschi, S., Silvestri, E., Di Scala, G., Iannone, F., Frediani, B., Galeazzi, M., Lapadula, G., Rigante, D., & Cantarini, L. (2019). Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4). Clinical Rheumatology, 38, 267-267. https://doi.org/10.1007/s10067-018-4302-0

@article{ec321b6342e04924a239a0d609d354c6,

title = "Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Beh{\c c}et{\textquoteright}s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)",

abstract = "A correction is reported in comparison with the original version of the paper.",

keywords = "Beh{\c c}et's disease, Beh{\c c}et's disease",

author = "Antonio Vitale and Giacomo Emmi and Giuseppe Lopalco and Claudia Fabiani and Stefano Gentileschi and Elena Silvestri and {Di Scala}, Gerardo and Florenzo Iannone and Bruno Frediani and Mauro Galeazzi and Giovanni Lapadula and Donato Rigante and Luca Cantarini",

year = "2019",

doi = "10.1007/s10067-018-4302-0",

language = "English",

volume = "38",

pages = "267--267",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "-Heidelberg : Springer, -Brussels : Acta Medica Belgica, [1982-",

}

Vitale, A, Emmi, G, Lopalco, G, Fabiani, C, Gentileschi, S, Silvestri, E, Di Scala, G, Iannone, F, Frediani, B, Galeazzi, M, Lapadula, G, Rigante, D & Cantarini, L 2019, 'Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)', Clinical Rheumatology, vol. 38, pagg. 267-267. https://doi.org/10.1007/s10067-018-4302-0

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4). / Vitale, Antonio; Emmi, Giacomo; Lopalco, Giuseppe et al.
In: Clinical Rheumatology, Vol. 38, 2019, pag. 267-267.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)

AU - Vitale, Antonio

AU - Emmi, Giacomo

AU - Lopalco, Giuseppe

AU - Fabiani, Claudia

AU - Gentileschi, Stefano

AU - Silvestri, Elena

AU - Di Scala, Gerardo

AU - Iannone, Florenzo

AU - Frediani, Bruno

AU - Galeazzi, Mauro

AU - Lapadula, Giovanni

AU - Rigante, Donato

AU - Cantarini, Luca

PY - 2019

Y1 - 2019

N2 - A correction is reported in comparison with the original version of the paper.

AB - A correction is reported in comparison with the original version of the paper.

KW - Behçet's disease

UR - http://hdl.handle.net/10807/191879

U2 - 10.1007/s10067-018-4302-0

DO - 10.1007/s10067-018-4302-0

M3 - Article

SN - 0770-3198

VL - 38

SP - 267

EP - 267

JO - Clinical Rheumatology

JF - Clinical Rheumatology

ER -

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo